[Source: People Daily, by Rebecca Mutiso]
Kenyan is among developing countries set to get access to affordable drugs from pharmaceutical firm, Novartis, to treat major symptoms of Covid-19 virus.
The portfolio of 15 generic and over-the-counter drugs will be used to treat inflammation and respiratory problems linked to Covid-19, given the fact that there is still no vaccine or curative treatment available to cure the disease.
Novartis Sub Saharan Head, Racey Muchilwa said the drugs, which are under the firm’s Pandemic Response Portfolio, will ease the demands Covid-19 pandemic has put on…
